Primary Retinal Detachment
Primary Retinal Detachment
Primary Retinal Detachment
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
156<br />
7 Pharmacological Approaches to Improve Surgical Outcomes<br />
5. Cowley M, Conway B, Campochiaro P, Kaiser D, Gaskin H (1989) Clinical<br />
risk factors for proliferative vitreoretinopathy. Arch Ophthalmol<br />
107:1147–1151<br />
6. Grizzard WS, Hilton GF (1982) Scleral buckling for retinal detachments<br />
complicated by periretinal proliferation.Arch Ophthalmol 100:<br />
419–422<br />
7. Sternberg P Jr, Machemer R (1985) Results of conventional vitreous<br />
surgery for proliferative vitreoretinopathy. Am J Ophthalmol 100:<br />
141–146<br />
8. Blumenkranz M, Hernandez E, Ophir A, Norton EWD (1984)<br />
5-Fluorouracil: new applications in complicated retinal detachment<br />
for an established antimetabolite. Ophthalmology 91:122–<br />
130<br />
9. Blumenkranz MS (1988) Management of complicated retinal detachment.<br />
In: Tso MOM (ed) <strong>Retinal</strong> diseases: biomedical foundations and<br />
clinical management. JB Lippincott, Philadelphia<br />
10. Asaria RH, Kon CH, Bunce C, Charteris DC et al (2001) How to predict<br />
proliferative vitreoretinopathy: a prospective study. Ophthalmology<br />
108:1184–1186<br />
11. Martidis A, Duker JS, Greenberg PB, Rogers AH et al (2002) Intravitreal<br />
triamcinolone for refractory diabetic macular edema. Ophthalmology<br />
109:920–927<br />
12. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E (2002)<br />
Intravitreal triamcinolone acetonide for macular oedema due to<br />
central retinal vein occlusion. Br J Ophthalmol 86:247–248<br />
13. Koerner F, Merz A, Gloor B, Wagner E (1982) Postoperative retinal<br />
fibrosis – a controlled clinical study of systemic steroid therapy.<br />
Graefes Arch Clin Exp Ophthalmol 219:268–271<br />
14. Machemer R (1977) Massive periretinal proliferation: a logical approach<br />
to therapy. Trans Am Ophthalmol Soc 75:556–586<br />
15. Blumenkranz MS, Hartzer MK (2000) The mechanism of action of<br />
drugs for the treatment of vitreoretinal scarring. In: Retina, vol. 3.<br />
Ryan S, Glaser B (eds) CV Mosby, St. Louis, pp 2281–2293<br />
16. Campochiaro PA, Bryan JA III, Conway BP, Jaccoma EH (1986)<br />
Intravitreal chemotactic and mitogenic activity implications of bloodretinal<br />
barrier breakdown. Arch Ophthalmol 104:1685–1687<br />
17. Campochiaro PA, Glaser BM (1986) Mechanisms involved in<br />
retinal pigment epithelial cell chemotaxis. Arch Ophthalmol 104:<br />
277–280